Xiamen Amoytop Biotech Co., Ltd.

This is an early-stage study to check the safety and basic effects of a new oral drug called ACT500 in people with fatty liver disease linked to metabolic problems like obesity or diabetes. About 24 participants will take the pill daily at different dose levels to see how their b…

This is a very early-stage study to check the safety of a new drug called ACT100, which is being developed for lupus. It will be tested in 48 healthy volunteers to see how their bodies react to it and how the drug moves through their system. The main goal is to find a safe dose a…